Small-scale Lung Cancer Therapeutics, and immunotherapy drugs will play a major role in the next 7 years and may grow at a CAGR of 7.44% globally. However, the same class of drugs might grow at a CAGR of 10.59% in the Non-Small-Scale Lung Cancer Therapeutics Market in the same time period.